000 | 03618cam a2200505 a 4500 | ||
---|---|---|---|
999 |
_c530 _d530 |
||
001 | 99106853360001452 | ||
003 | MACHS | ||
005 | 20210413150458.0 | ||
008 | 990322s1999 ctua b 001 0 eng | ||
010 | _a 99072672 | ||
015 |
_aGB99X9724 _2bnb |
||
016 | 7 |
_a100892388 _2DNLM |
|
020 | _a0838576915 | ||
020 | _a9780838576915 | ||
035 |
_a(OCoLC)41487103 _z(OCoLC)41311437 _z(OCoLC)49857814 |
||
035 | _a(OCoLC)ocm41487103 | ||
035 | _a(EXLNZ-01ALLIANCE_NETWORK)99178465970001451 | ||
040 |
_aDLC _beng _cDLC _dNLM _dVAQ _dKUM _dUKM _dMUQ _dOCLCQ _dNLGGC _dBTCTA _dYDXCP _dKGN _dTULIB _dOCLCF _dOCLCO _dOCLCQ _dOCLCO _dOCLCA |
||
049 | _aMAIN | ||
050 | 0 | 0 |
_aRM263 _b.P56 2000 |
060 | 0 | 0 |
_aWB 330 _bP5357 1999 |
082 | 0 | 0 |
_a615.5/8 _221 |
084 |
_a44.38 _2bcl |
||
245 | 0 | 0 |
_aPharmacotherapy : _ba pathophysiologic approach / _ceditors, Joseph T. DiPiro [and others]. |
250 | _a4th ed. | ||
260 |
_aStamford, Conn. : _bAppleton & Lang, _c©1999. |
||
300 |
_axxv, 2440 pages : _billustrations ; _c29 cm |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_aunmediated _bn _2rdamedia |
||
338 |
_avolume _bnc _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | 0 |
_tGuiding Principles of Pharmacotherapy -- _gSect. 1. _tBasic Concepts -- _g1. _tPharmacoeconomics: Principles / _rLisa A. Sanchez -- _g2. _tHealth Outcomes and Quality of Life / _rStephen Joel Coons -- _g3. _tClinical Pharmacokinetics and Pharmacodynamics / _rLarry A. Bauer -- _g4. _tPediatrics / _rMilap C. Nahata -- _g5. _tGeriatrics / _rJoseph T. Hanlon, Christine M. Ruby and Penny S. Shelton / _r[and others] -- _g6. _tPharmacoepidemiology / _rAndy Stergachis and Thomas K. Hazlet -- _g7. _tClinical Toxicology / _rPeter A. Chyka -- _gSect. 2. _tCardiovascular Disorders -- _g8. _tCardiovascular Testing / _rMargaret E. McGuinness and Robert L. Talbert -- _g9. _tCardiopulmonary Resuscitation / _rLori A. Jones -- _g10. _tHypertension / _rDavid W. Hawkins, Henry I. Bussey and L. Michael Prisant -- _g11. _tHeart Failure / _rJulie A. Johnson, Robert B. Parker and Stephen A. Geraci -- _g12. _tIschemic Heart Disease / _rRobert L. Talbert -- _g13. _tMyocardial Infarction / _rKathleen A. Stringer and Larry M. Lopez -- _g14. _tArrhythmias / _rJerry L. Bauman and Marieke Dekker Schoen -- _g15. _tCardiomyopathies / _rJean Nappi -- _g16. _tCardiac Transplantation / _rKathleen D. Lake and Maria-Teresa Olivari -- _g17. _tThromboembolic Disorders / _rSharon M. Erdman, Susan K. Chuck and Keith A. Rodvold -- _g18. _tStroke / _rJ. Chris Bradberry -- _g19. _tHyperlipidemia / _rRobert L. Talbert -- _g20. _tPeripheral Vascular Disease / _rRobert L. Talbert -- _g21. _tUse of Vasopressors and Inotropes in the Pharmacotherapy of Shock / _rMaria I. Rudis, Bertil Wagner and Joseph F. Dasta -- _g22. _tHypovolemic Shock / _rBrian L. Erstad -- _gSect. 3. _tRespiratory Disorders -- _g23. _tPulmonary Function Testing / _rJay I. Peters and David C. Shelledy -- _g24. _tAsthma / _rH. William Kelly and Alan K. Kamada -- _g25. _tChronic Obstructive Lung Disease / _rSherri L. Konzem and Mark A. Stratton -- _g26. _tRespiratory Distress Syndrome / _rPeter Gal, Sharon M. Watling and Christopher L. Shaffer. |
650 | 0 | _aChemotherapy. | |
650 | 0 | _aPhysiology, Pathological. | |
650 | 1 | 2 | _aDrug Therapy. |
650 | 6 | _aChimiothérapie. | |
650 | 6 | _aPhysiopathologie. | |
650 | 7 |
_aChemotherapy. _2fast _0(OCoLC)fst00853595 |
|
650 | 7 |
_aPhysiology, Pathological. _2fast _0(OCoLC)fst01063216 |
|
650 | 1 | 7 |
_aFarmacotherapie. _2gtt |
650 | 1 | 7 |
_aPathologische fysiologie. _2gtt |
700 | 1 | _aDiPiro, Joseph T. | |
942 |
_2lcc _cBK |